Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 301-320 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 301 | Emposat lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only gives contextual membership rationale that Emposat provides ground-station access used in connection with a surveillance satellite, which is too indirect to support a durable positive investment thesis without direct within the recent evidence window business evidence. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Emposat. Caveats: Phase-2 membership rationale references articles and, but the reviewed sources provide no for citation. Ground-station context is indirect and not enough for a strong thesis under the evidence standard. |
| 302 | EnduroSat lowweak | Opp 1 Risk 1 | Thesis: Insufficient admissible reviewed sources evidence to support a positive thesis within the selected recent evidence window, despite membership rationale describing EnduroSat as a space infrastructure and satellite-constellation builder. Why now: Why now is unsupported because no evidence remain after recent evidence filtering; there is no dated catalyst, financing, contract, production, or customer evidence available here. Caveats: No surviving evidence after recent evidence filtering. Reviewed evidence counts indicate evidence existed upstream, but none is included here for direct citation. Low scores reflect missing evidence, not a fundamental negative judgment. |
| 303 | EON Space Labs lowweak | Opp 1 Risk 3 | Thesis: No positive thesis is supportable from the scoring evidence fields because no direct positive evidence are provided. Why now: Why now is stronger than for most names here because the phase2 rationale specifically ties EON Space Labs to a PSLV failure context via article: implying a concrete event rather than generic company context. However, conviction remains low because the reviewed sources omits the underlying event summary and dates in the evidence exposed here. Caveats: The adverse signal appears only in phase2 rationale, not in direct negative evidence. No article summary, quote, or timing detail is provided in the scoring fields. Impact magnitude on EON specifically cannot be quantified from these reviewed sources alone. |
| 304 | FOSSA Systems lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources' membership rationale says FOSSA Systems has launched 24 satellites, is deploying an 80-satellite constellation, and has defense customers, but there are no available direct positive evidence or dated representative articles within the reviewed sources for scoring, so opportunity remains only a watchlist possibility. Why now: No within the recent evidence window evidence are available after filtering, so there is no near-dated trigger or state change that can be scored from the local reviewed sources. Caveats: Membership support references article, but that article content is not available here for direct citation. Coverage debug shows zero evidence after recent evidence window. A positive thesis requires positive evidence, not just category fit or membership rationale. |
| 305 | GalaxEye Space Solutions Private Ltd lowweak | Opp 1 Risk 2 | Thesis: The company belongs in the cohort as an Earth observation / SAR startup, but these reviewed sources provide no available within the recent evidence window directional evidence to support a strong 1 year+ opportunity thesis. Why now: There is no within the recent evidence window evidence available for this entity in the reviewed sources; recency of any business progress is uncertain. Caveats: Evidence recent evidence review shows 0 kept rows after the 90-day cutoff for this entity. Membership rationale references article IDs, and: but no article summaries or direct evidence are included in these reviewed sources for citation-level use. Scores are constrained by absence of directional evidence, not by a proven negative business outcome. |
| 306 | GE Aerospace lowweak | Opp 1 Risk 1 | Thesis: No reviewed sources-supported positive thesis is available. The company is only described as appearing in generic 'space stocks' context, while direct positive evidence after the 90-day recent evidence window is absent. Why now: There is no current catalyst in the reviewed sources. Coverage shows 32 article IDs considered but zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency-based ranking is not supported. Caveats: Phase2 rationale says only generic stock-screener style article context was available, citing article IDs, and, but no were provided in the reviewed sources. Evidence recent evidence review shows no current evidence was retained and undated_rows_kept = 0. Without for the cited membership-support articles, they cannot be used as factual thesis evidence under the citation requirement. |
| 307 | Gilat Satellite Networks Ltd. lowweak | Opp 1 Risk 1 | Thesis: Insufficient retained local evidence within the 90-day recent evidence window to support a positive 1 year+ opportunity thesis. Why now: No company-specific dated evidence were retained after the 90-day recent evidence window cutoff of March 29, 2026, so there is no current catalyst basis in the reviewed sources. Caveats: Reviewed evidence shows 64 articles considered but 0 article IDs after recent evidence window and 0 evidence retained. Membership support cited article IDs: and: but no article summaries or retained evidence are provided in these reviewed sources, so no factual thesis claims can be grounded from them. |
| 308 | Hensoldt AG lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources offers no direct positive company-specific evidence within the available scoring set. The membership rationale says Hensoldt appears in a market report as one of many key players in the space situational awareness market, but that is article-level market-list context rather than direct business evidence, and no available evidence remain after recent evidence window. Why now: No near-term or durable catalyst is established from the available evidence. Coverage debug shows 69 article IDs considered but 0 after recent evidence window and 0 evidence after dedupe. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Only context-level market-list mention is described, not a direct event or fact. |
| 309 | HEO USA lowweak | Opp 1 Risk 1 | Thesis: A limited positive angle exists because the membership rationale says a HEO camera achieved sub-5-meter resolution in Sidus Space's earnings context, implying technical relevance (: and: unavailable in reviewed sources). However, this appears indirect and counterparty/component context rather than direct company evidence, so opportunity remains low. Why now: Why now is weak because the cited technical-performance context is indirect, and the reviewed sources explicitly warns that relations are context-only and should not be used as counterparty propagation evidence. Caveats: No current evidence is provided for: and Counterparty/component context is not strong direct evidence for HEO USA itself. Zero evidence available after recent evidence window. |
| 310 | Hermeus Corporation lowweak | Opp 1 Risk 1 | Thesis: No direct positive evidence is available. The reviewed sources say Hermeus is only mentioned as one of several companies expanding in California in an article about Skydio, which is too indirect to support a durable positive thesis. Why now: There is no current timing signal from the reviewed sources. Coverage debug shows 29 article IDs considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. The only described mention is indirect article context. |
| 311 | HughesNet lowweak | Opp 1 Risk 2 | Thesis: The reviewed sources places HughesNet within satellite broadband and communication services context via EchoStar, but there is no direct reviewed evidence in the 90-day window to support a differentiated 1 year+ opportunity thesis. Why now: There is no validated near-term or long-term catalyst from active evidence. The reviewed sources cites article in membership support, but the company coverage section shows zero articles after recent evidence window and zero evidence after recent evidence window, so recency-backed thesis formation is not possible. Caveats: High article count does not equal conviction; no post-recent evidence window evidence was available. No direct company-specific event/fact evidence is available in the output reviewed sources. |
| 312 | Impulso lowweak | Opp 1 Risk 1 | Thesis: There is no direct positive evidence in the available scoring set. The reviewed sources say Impulso is mentioned only as GalaxEye's distribution agreement counterparty, which does not establish Impulso's own business opportunity. Why now: No timing catalyst is supported by the reviewed sources. Coverage debug shows 1 article considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Counterparty context cannot be propagated into a direct thesis. |
| 313 | Infinite Orbits lowweak | Opp 1 Risk 1 | Thesis: Potential long-horizon opportunity exists if the previously referenced multi-launch agreement for servicing satellites remains active, but the reviewed sources provide no retained within the recent evidence window positive evidence to support a current thesis. Why now: There is no qualifying 90-day retained evidence. The only cited article mentioning Infinite Orbits is dated September 16, 2025, outside the reviewed sources' 90-day recent evidence window, so recency for any business progress is not established. Caveats: Reviewed evidence shows zero evidence retained after recent evidence window. Do not use the older TechCrunch article as current recency proof. Absence of recent negative evidence is not positive evidence. |
| 314 | Integrate lowweak | Opp 1 Risk 1 | Thesis: No current positive thesis is supportable within the reviewed sources' retained recent evidence window evidence. Why now: Why now is weak because the only specific company article summary in the reviewed sources were dated February 23, 2026 and was dropped by the 90-day recent evidence window, so it cannot support current ranking despite mentioning financing and a Space Force contract, February 23, 2026). Caveats: The reviewed sources contain a representative article summary for stating Integrate 'closed a $17M Series A and landed a $25M space force contract to deploy secure program management software,' but the evidence recent evidence review says those rows were dropped as older than the March 29, 2026 cutoff, so they are not usable for current scoring. The company may be space-adjacent software rather than a direct space operator, per the reviewed sources' own membership rationale. |
| 315 | Integrated Launch Solutions, Inc. lowweak | Opp 1 Risk 1 | Thesis: No positive thesis can be supported from retained evidence because the reviewed sources contain no direct positive rows within the recent evidence window. Why now: No current catalyst is evidenced in retained rows. Caveats: Phase-2 rationale says ILS provides engineering, mission design, range integration, and support for the STARLAUNCH pathway and cites: and: but neither summary nor is available here for citation. Coverage debug shows 7 articles considered and 0 after recent evidence window. Service-provider context alone is not directional proof without retained positive or negative evidence. |
| 316 | Integrity ISR lowweak | Opp 1 Risk 1 | Thesis: No positive thesis can be supported because there is no retained direct positive evidence within the reviewed sources' recent evidence window. Why now: No current business change or catalyst is evidenced in the retained rows. Caveats: Phase-2 rationale references: about analysis of satellite maneuvers near an ICEYE satellite, but no or article summary is provided here for citation. Coverage debug shows 1 article considered and 0 after recent evidence window. Single-article descriptive context in phase-2 rationale is weaker than direct event/fact evidence and is uncitable here due to missing. |
| 317 | Israel Aerospace Industries lowweak | Opp 1 Risk 1 | Thesis: No admissible direct positive evidence was available inside the 90-day recent evidence window, so there is no supportable positive 1 year+ opportunity thesis from these reviewed sources alone. Why now: There is no usable current evidence in the reviewed sources for this company: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale references article: but no company-specific evidence are available for ranking use. unavailable in reviewed sources. Caveats: Reviewed evidence provides no post-recent evidence window evidence. Membership rationale is not directional proof. Referenced: has no in the reviewed sources. |
| 318 | Kepler Communications lowweak | Opp 1 Risk 1 | Thesis: Kepler may have long-horizon potential because the membership rationale says it operates an optical relay satellite network and is prime contractor on ESA HydRON optical communications work, but there is no available within the recent evidence window evidence in these reviewed sources to substantiate a directional score. Why now: There is no scoreable current catalyst because the reviewed sources contain no reviewed evidence after the 90-day recent evidence filter for this company. Caveats: Membership rationale cites, and, but the supporting article details are not available here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. No current dated evidence means recency is uncertain. |
| 319 | Kessler Dynamics lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence hints only that Kessler Dynamics was listed in a spacetech accelerator with themes including rocket propulsion, satellites, and space energy, but no in-recent evidence window direct evidence or article is provided, so there is no supported positive thesis. Why now: There is no usable dated catalyst evidence in the reviewed sources for the 1 year+ horizon. The reviewed sources show 0 reviewed evidence after the 90-day cutoff and no representative article summary or for direct citation. Caveats: Coverage is effectively empty after recent evidence filtering: evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0. The reviewed sources references support references including: but no or quote/summary is provided, so it cannot support factual claims under the citation rule. |
| 320 | KinetX lowweak | Opp 1 Risk 1 | Thesis: No direct positive evidence is available, so there is no supportable opportunity thesis from these reviewed sources alone. Why now: The only described context is that Intuitive Machines 'closed KinetX transaction' in article, but no business description, no, and no evidence are available after recent evidence filtering. Caveats: Acquisition context alone is not directional proof for KinetX. No company-specific operating facts are available. Referenced has no in the reviewed sources. |
Risk view
Showing rows 401-420 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 401 | ULA lowweak | Opp 1 Risk 1 | Thesis: There is no retained 90-day negative evidence to support a material risk case. Why now: Coverage data shows zero retained article IDs and evidence after the recent evidence filter, so there is no recent thesis-driving evidence in the reviewed sources. Caveats: Only membership-level context is present in the served reviewed sources. No direct event, fact, or article-context evidence remains within the recent evidence window. Direction cannot be inferred from category membership alone. |
| 402 | Uncovr lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available, but absence of negative evidence is not a positive thesis. Why now: The only described context is a funding-roundup article referenced in phase2 rationale, but no post-recent evidence window evidence or are provided for thesis use. Caveats: Phase2 rationale says Uncovr was listed as having raised $7M in article: but no was provided in the reviewed sources. Despite support_counts mentioning dated event/facts, the company-level available evidence arrays are empty and coverage data shows evidence after recent evidence window = 0. Broad funding roundup context is weaker than direct company-specific event evidence. |
| 403 | United Launch Alliance lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is provided in the reviewed sources after recent evidence filtering, so a negative thesis is not established either. Why now: Why now is unsupported because the reviewed sources contain no surviving article or evidence after the selected recent evidence window; business-state or catalyst timing cannot be judged from the provided materials. Caveats: Zero evidence survived after recent evidence filtering. Company membership in the cohort is not thesis attractiveness. No dated catalyst, performance update, or direct risk item is included. |
| 404 | Univity lowweak | Opp 1 Risk 1 | Thesis: A large planned constellation and early-stage buildout could imply execution risk, but the reviewed sources provide no direct adverse evidence within the available evidence set. Why now: No usable within the recent evidence window evidence were available after filtering; recency-based thesis formation is therefore not supported in these reviewed sources. Caveats: Coverage after recent evidence window is effectively empty in these reviewed sources. Membership rationale is not directional proof. |
| 405 | Vantor lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is retained in the reviewed sources, so there is no evidence-based risk thesis at present. Why now: Why now is weak because the reviewed sources contain no retained post-cutoff directional evidence. Caveats: Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Membership rationale references article IDs without and cannot be cited directly here. |
| 406 | Varda Space Industries lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources also contains no retained 90-day direct negative evidence, so there is not enough support for a material adverse thesis either. Why now: No within the recent evidence window company-specific evidence were available after filtering; articles after recent evidence window and evidence after recent evidence window are both zero in coverage data, so recency-based thesis formation is not supported in these reviewed sources. Caveats: 12 articles were considered historically, but zero article IDs remained after the 90-day recent evidence filter. Membership rationale cites older support article IDs but those underlying evidence are not retained in the served reviewed sources. Scores are constrained by evidence absence, not by a documented negative business development. |
| 407 | Veact lowweak | Opp 0 Risk 1 | Thesis: No material adverse thesis is supported either; the main issue is insufficient evidence rather than identified business deterioration. Why now: No why-now catalyst is supported because the reviewed sources contain no post-recent evidence window evidence. Caveats: Phase2 rationale references article: but no was provided in the reviewed sources. A broad funding roundup is not enough to establish thesis direction. Coverage data shows articles after recent evidence window = 0. |
| 408 | Venturi Astrolab lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is retained in these reviewed sources. Why now: Why now is weak because despite 30 articles considered, coverage data shows articles after recent evidence window of 0 and evidence recent evidence review kept_rows of 0, so the reviewed sources does not preserve dated supporting evidence inside the 90-day window. Caveats: Phase-2 rationale cannot substitute for cited article evidence because are absent. No direct positive or negative evidence arrays are populated. Low scores are driven by evidence retention limits in these reviewed sources. |
| 409 | Virgin Galactic Holdings, Inc. lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not provide direct negative evidence inside the scoring fields, so no material adverse thesis is supportable here. Why now: The phase2 rationale references three article IDs, but the reviewed sources includes no representative article summaries or evidence to cite for a dated catalyst. Coverage data shows zero article IDs after recent evidence window and zero available evidence, so the current-state thesis is unsupported by reviewed sources detail. Caveats: Do not infer direction from company identity or sector relevance alone. Phase2 membership support cannot substitute for direct thesis evidence. |
| 410 | Volteum lowweak | Opp 0 Risk 1 | Thesis: No direct negative evidence is available; current ranking is constrained by missing evidence rather than identified downside events. Why now: No catalyst is supported in the reviewed sources due to zero post-recent evidence window evidence. Caveats: Phase2 rationale references article: but no was provided in the reviewed sources. Funding-roundup presence alone is not directional proof. Evidence strength remains minimal. |
| 411 | Vyoma GmbH lowweak | Opp 1 Risk 1 | Thesis: No material negative evidence is supplied after recent evidence filtering, so a risk thesis is not supported either. Why now: Why now is unsupported because the reviewed sources contain no surviving evidence after recent evidence filtering; timing and business-state changes cannot be validated from the provided material. Caveats: Zero evidence after recent evidence filtering. Membership rationale alone is not sufficient for directional scoring. No direct dated catalyst or adverse development is provided. |
| 412 | Windward lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is retained. The main risk is classification ambiguity and weak grounding, not a documented negative event. Why now: There is no validated within the recent evidence window catalyst. The only support cited is phase-2 rationale referencing, and without or retained evidence. Caveats: Reviewed evidence language distinguishes maritime domain awareness from space domain awareness. No retained article summaries or evidence are available after recent evidence window. Context-only relations must not be propagated into stronger thesis claims. |
| 413 | Windward Ltd. lowweak | Opp 1 Risk 1 | Thesis: There is no direct negative evidence. The only notable issue is that the available mention is relation context, which is insufficient for a real risk thesis. Why now: No catalyst is established. Coverage debug shows 27 article IDs considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Relation context is explicitly weaker and not valid counterparty propagation evidence. |
| 414 | WISeKey International Holding Ltd lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources provide no retained within the recent evidence window direct negative evidence to support a risk thesis. Why now: There are zero available evidence after recent evidence window for ranking, so no evidence-backed timing signal is available. Caveats: Membership support mentions 21 LEO satellites launched and operational space-related infrastructure, but those claims are not accompanied here by retained ranking evidence or article. Without dated evidence inside the recent evidence window, score should remain low-conviction. |
| 415 | York Space Systems lowweak | Opp 1 Risk 1 | Thesis: No retained within the recent evidence window negative evidence was available, so the reviewed sources does not support a material risk thesis. Why now: The reviewed sources have no retained dated evidence after the 90-day recent evidence window, so there is no citable timing edge for a 1 year+ ranking. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites article IDs and, but no or retained evidence text are provided here. Later-dated evidence could supersede older listing or contract-status claims, but no such retained evidence exists in these reviewed sources. |
| 416 | York Space Systems lowweak | Opp 1 Risk 1 | Thesis: There is no retained adverse evidence in the active recent evidence window, so only a minimal risk score is warranted. Why now: Although membership support cites articles, and: no representative summaries or retained evidence are included here, leaving no current catalyst basis. Caveats: 54 articles considered, but 0 retained after recent evidence filtering. Cannot elevate based on membership rationale alone. |
| 417 | Zaro lowweak | Opp 0 Risk 1 | Thesis: No reviewed sources-supported negative thesis is available either; the issue is missing evidence rather than documented adverse developments. Why now: There is no current or durable catalyst supported by the reviewed sources because no evidence survived into the available post-recent evidence window set. Caveats: Phase2 rationale references article: but no was provided in the reviewed sources. General funding-roundup context is weaker than direct event or fact evidence. Coverage remains insufficient for a directional call. |
| 418 | Zoove Space lowweak | Opp 2 Risk 1 | Thesis: No direct negative evidence is supplied. Main risk is that accelerator participation alone is weak support for a durable commercial thesis. Why now: The reviewed sources offers no in-window evidence to confirm timing beyond the phase-2 rationale, so the current catalyst strength is limited. Caveats: No evidence remained after the 90-day recent evidence window. Accelerator selection is a weak signal relative to financing, contracts, or operating milestones. No direct dated article is available in the reviewed sources body. |
| 419 | Akashalabdhi lowweak | Opp 0 Risk 0 | Thesis: No negative thesis is supportable because the reviewed sources contain no direct negative evidence for Akashalabdhi within the recent evidence window. Why now: There is no visible near-term or long-horizon company-specific catalyst in the reviewed sources. The membership review explicitly says the only included article does not mention Akashalabdhi in the visible summary, and coverage debug shows zero articles and zero evidence after recent evidence window. Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article. Evidence recent evidence review shows 0 kept rows after the March 29, 2026 cutoff. The reviewed sources itself says visible evidence is insufficient to determine even qualifying membership. |
| 420 | Amentum Holdings Inc. lowweak | Opp 0 Risk 0 | Thesis: No negative thesis is supportable from retained reviewed sources evidence because there are no direct negative evidence and no articles retained after the 90-day recent evidence window. Why now: No current catalyst is evidenced in the retained reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window despite large historical mention volume. Caveats: Phase-2 rationale references article IDs and, but no article summaries or retained evidence are included here. Historical aerospace exposure does not create a current directional thesis without retained evidence. |